GERMANY EIB
March 1st, 2005
BY KEITH NUTHALLTHE EUROPEAN Investment Bank (EIB) is planning to lend around Euro 40 million to Germany's Impfstoffwerk Dessau-Tornau to help it build a new research and development building and a new production facility for virus vaccines. The loan would also part-fund the reconstruction of a filling unit, the expansion of existing cooling, storage and vaccine production facilities plus investments in equipment. The overall cost of these projects is estimated at Euro 100 million and the bank has noted approvingly that they will create 197 jobs in the company's ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.